新天药业
(002873)
| 流通市值：18.41亿 | | | 总市值：18.75亿 |
| 流通股本：2.40亿 | | | 总股本：2.44亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 178,610,160.01 | 749,720,071.32 | 558,633,030.72 | 358,286,117.72 |
| 营业总成本 | 174,084,468.5 | 744,175,673.38 | 545,335,763.62 | 354,583,092.36 |
| 其他经营收益 | | | | |
| 营业利润 | 5,229,045.38 | 10,071,031.97 | 16,939,077.81 | 6,547,075.35 |
| 利润总额 | 5,245,449.07 | 9,769,456.61 | 16,671,557.39 | 6,269,691.02 |
| 净利润 | 3,495,173.12 | 9,111,475.81 | 16,180,940.17 | 5,766,078.35 |
| 每股收益 | | | | |
| 其他综合收益 | - | 66,535,046.25 | 66,535,046.25 | - |
| 综合收益总额 | 3,495,173.12 | 75,646,522.06 | 82,715,986.42 | 5,766,078.35 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 614,129,490.15 | 651,035,036.56 | 653,829,552.55 | 559,997,789.31 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,477,650,069.41 | 1,470,039,271.29 | 1,439,103,802.84 | 1,323,981,895.61 |
| 资产总计 | 2,091,779,559.56 | 2,121,074,307.85 | 2,092,933,355.39 | 1,883,979,684.92 |
| 流动负债: | | | | |
| 流动负债合计 | 457,226,805.08 | 380,195,259.93 | 301,764,019.99 | 211,170,394.75 |
| 非流动负债: | | | | |
| 非流动负债合计 | 374,813,078.16 | 484,634,544.72 | 527,855,367.84 | 486,445,230.68 |
| 负债合计 | 832,039,883.24 | 864,829,804.65 | 829,619,387.83 | 697,615,625.43 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,259,739,676.32 | 1,256,244,503.2 | 1,263,313,967.56 | 1,186,364,059.49 |
| 股东权益合计 | 1,259,739,676.32 | 1,256,244,503.2 | 1,263,313,967.56 | 1,186,364,059.49 |
| 负债和股东权益合计 | 2,091,779,559.56 | 2,121,074,307.85 | 2,092,933,355.39 | 1,883,979,684.92 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 200,090,397.92 | 852,090,617.14 | 664,864,099.45 | 419,303,258.7 |
| 经营活动现金流出小计 | 156,471,670.78 | 768,355,874.81 | 548,868,177.11 | 352,116,158.56 |
| 经营活动产生的现金流量净额 | 43,618,727.14 | 83,734,742.33 | 115,995,922.34 | 67,187,100.14 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 15,000,000 | 17,149,190.1 | 16,887,132.6 | 16,887,132.6 |
| 投资活动现金流出小计 | 34,935,053.48 | 109,581,316.55 | 84,978,532.93 | 35,577,344.48 |
| 投资活动产生的现金流量净额 | -19,935,053.48 | -92,432,126.45 | -68,091,400.33 | -18,690,211.88 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 23,612,500 | 532,750,971.36 | 431,900,000 | 287,000,000 |
| 筹资活动现金流出小计 | 53,890,547.66 | 468,498,440.32 | 428,543,674.11 | 359,193,749.79 |
| 筹资活动产生的现金流量净额 | -30,278,047.66 | 64,252,531.04 | 3,356,325.89 | -72,193,749.79 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -6,594,374 | 55,555,146.92 | 51,260,847.9 | -23,696,861.53 |
| 期末现金及现金等价物余额 | 167,125,200.8 | 173,719,574.8 | 169,425,275.78 | 94,467,566.35 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | 55,555,146.92 | - | -23,696,861.53 |